Invention Grant
- Patent Title: Infusion pressure control using blood pressure
-
Application No.: US14293613Application Date: 2014-06-02
-
Publication No.: US10463533B2Publication Date: 2019-11-05
- Inventor: Steven T. Charles
- Applicant: Novartis AG
- Applicant Address: CH Basel
- Assignee: Novartis AG
- Current Assignee: Novartis AG
- Current Assignee Address: CH Basel
- Main IPC: A61B3/16
- IPC: A61B3/16 ; A61B5/00 ; A61M35/00 ; A61F9/007 ; A61M5/172

Abstract:
Methods, systems, and software for controlling infusion pressure, such as during a medical procedure, using systemic blood pressure are described. Systemic blood pressure, such as brachial arm blood pressure or radial artery blood pressure, may be used to estimate central retinal artery blood pressure to estimate critical closing pressure. Further, the disclosure relates to controlling infusion pressure to prevent an increase in intraocular pressure above the estimated critical closing pressure when such is not desired, and, when such is desired, using systemic blood pressure and infusion pressure to control an intentional increase in intraocular pressure above the estimated critical closing pressure to stop intraocular bleeding.
Public/Granted literature
- US20140276558A1 INFUSION PRESSURE CONTROL USING BLOOD PRESSURE Public/Granted day:2014-09-18
Information query